Compare Southern Company (SO) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Southern Company vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Southern Company trades at $86.29 (market cap $98.29B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: Southern Company is the larger of the two by market cap, and Southern Company pays the higher dividend (3.56%). Which is the better fit depends on your goals — on Pluang, investors hold Southern Company for 12 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| SO | TAK | |
|---|---|---|
Market Cap | $98.29B | $58.16B |
Volume | 5,624,994 | 2,467,530 |
Sector | Utilities | Health |
52-Week High | $99.72 | $19.05 |
52-Week Low | $82.35 | $13.23 |
Typical Hold Time | 12 Days | 0 Days |
Enterprise Value | $172.39B | $86.04B |
Dividend Yield | 3.56% | 3.36% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Southern Company
Southern Company is a U.S. energy company with electric and gas utility businesses. Its power generation portfolio includes natural gas, nuclear, renewable, and other energy sources.
Read more on SO →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
